Many of the 11 infants had significant morbidities including bronchopulmonary dysplasia, necrotizing enterocolitis and ileal perforation, and experienced longer hospital stays than a group of ...
Shares of Mirum Pharmaceuticals, Inc. (NASDAQ:MIRM – Get Free Report) have been given a consensus rating of “Buy” by the eleven analysts that are presently covering the firm, Marketbeat.com reports.
Crohn disease is a chronic condition characterised by intestinal inflammation and progressive bowel damage associated with impaired functioning. In rheumatoid arthritis, which shares some common ...